Yu-Long Hu
Overview
Explore the profile of Yu-Long Hu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Yang F, Chen Y, Shen S, Yan Y, Zhang Y, et al.
Yi Chuan
. 2024 Jul;
46(7):560-569.
PMID: 39016089
Genomic prediction has emerged as a pivotal technology for the genetic evaluation of livestock, crops, and for predicting human disease risks. However, classical genomic prediction methods face challenges in incorporating...
2.
Hu Y, Ma Q, Dong X, Kong Y, Cai J, Li J, et al.
Front Nutr
. 2023 Mar;
10:1107551.
PMID: 36969821
Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is...
3.
Hu Y, Wang Z, Yang H, Chen J, Wu Z, Lei Y, et al.
Chem Sci
. 2019 Aug;
10(28):6777-6784.
PMID: 31391898
Central-to-axial chirality conversion provides efficient access to axially chiral compounds, and several examples regarding the conversion of one, two or four stereocenters to one axis have been reported. Herein, we...
4.
Xu W, Zhang H, Hu Y, Yang H, Chen J, Zhou L
Org Lett
. 2018 Sep;
20(18):5774-5778.
PMID: 30182721
An efficient dehydrogenative Diels-Alder reaction of prenyl derivatives with dienophiles has been developed. The reaction exhibits broad substrate scope and provides efficient access to cyclohexene derivatives with good to excellent...
5.
Li N, Yin X, Wei X, Lu W, Shen S, Xiao L, et al.
Zhongguo Ying Yong Sheng Li Xue Za Zhi
. 2018 Jun;
34(2):145-149.
PMID: 29926679
Objectives: To investigate the interventional effects of 16-week aerobic exercises on the elderly's arteriosclerosis and its mechanism. Methods: Twenty-seven elderly people with the average age of 62. 70 ±3. 26...
6.
Feng Y, Hu Y, Wang H, Cao F
Acta Crystallogr C Struct Chem
. 2015 Aug;
71(Pt 8):679-82.
PMID: 26243414
A new linear bismuth(III) coordination polymer, catena-poly[[chloridobismuth(III)]-μ3-1,10-phenanthroline-2,9-dicarboxylato-κ(6)O(2):O(2),N(1),N(10),O(9):O(9)], [Bi(C14H6N2O4)Cl]n, has been obtained by an ionothermal method and characterized by elemental analysis, energy-dispersive X-ray spectroscopy, IR spectroscopy, thermal stability studies and single-crystal...
7.
Jahangiri A, De Lay M, Miller L, Carbonell W, Hu Y, Lu K, et al.
Clin Cancer Res
. 2013 Jan;
19(7):1773-83.
PMID: 23307858
Purpose: To identify mediators of glioblastoma antiangiogenic therapy resistance and target these mediators in xenografts. Experimental Design: We conducted microarray analysis comparing bevacizumab-resistant glioblastomas (BRG) with pretreatment tumors from the...
8.
Hu Y, Jahangiri A, Delay M, Aghi M
Cancer Res
. 2012 Aug;
72(17):4294-9.
PMID: 22915758
Autophagy is a lysosomal degradation pathway that can sequester cytosolic material, including organelles, nonspecifically in a process called nonselective macroautophagy, or target specific protein aggregates designated for destruction in a...
9.
Hu Y, Jahangiri A, De Lay M, Aghi M
Autophagy
. 2012 Jun;
8(6):979-81.
PMID: 22714142
While anti-angiogenic therapy was initially greeted enthusiastically by the cancer community, initial successes with this therapeutic modality were tempered by the failure of angiogenesis inhibitors to produce sustained clinical responses...
10.
Delay M, Jahangiri A, Carbonell W, Hu Y, Tsao S, Tom M, et al.
Clin Cancer Res
. 2012 Apr;
18(10):2930-42.
PMID: 22472177
Purpose: To identify mechanisms and mediators of resistance to antiangiogenic therapy in human glioblastoma. Experimental Design: We carried out microarray gene expression analysis and immunohistochemistry comparing 21 recurrent glioblastomas progressing...